Marin Gemmill

439 total citations
9 papers, 290 citations indexed

About

Marin Gemmill is a scholar working on Economics and Econometrics, General Health Professions and Pharmacology. According to data from OpenAlex, Marin Gemmill has authored 9 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 4 papers in General Health Professions and 2 papers in Pharmacology. Recurrent topics in Marin Gemmill's work include Healthcare Policy and Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Pharmaceutical Economics and Policy (5 papers). Marin Gemmill is often cited by papers focused on Healthcare Policy and Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Pharmaceutical Economics and Policy (5 papers). Marin Gemmill collaborates with scholars based in United Kingdom and Spain. Marin Gemmill's co-authors include Joan Costa‐Font, Elías Mossialos, Sarah Thomson, Panos Kanavos, Alistair McGuire and Sherry Merkur and has published in prestigious journals such as Journal of the Royal Statistical Society Series A (Statistics in Society), Health Economics and International Journal for Equity in Health.

In The Last Decade

Marin Gemmill

9 papers receiving 265 citations

Peers

Marin Gemmill
Jaeun Shin South Korea
Elizabeth Docteur United States
Ana Xavier Portugal
Daniel Garrett United States
Maria Polyakova United States
Marin Gemmill
Citations per year, relative to Marin Gemmill Marin Gemmill (= 1×) peers Christoph Schwierz

Countries citing papers authored by Marin Gemmill

Since Specialization
Citations

This map shows the geographic impact of Marin Gemmill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marin Gemmill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marin Gemmill more than expected).

Fields of papers citing papers by Marin Gemmill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marin Gemmill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marin Gemmill. The network helps show where Marin Gemmill may publish in the future.

Co-authorship network of co-authors of Marin Gemmill

This figure shows the co-authorship network connecting the top 25 collaborators of Marin Gemmill. A scholar is included among the top collaborators of Marin Gemmill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marin Gemmill. Marin Gemmill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Costa‐Font, Joan & Marin Gemmill. (2010). Does Cost Sharing Really Reduce Inappropriate Prescriptions. SSRN Electronic Journal. 27 indexed citations
2.
Costa‐Font, Joan, et al.. (2010). Biases in the Healthcare Luxury Good Hypothesis?: A Meta-Regression Analysis. Journal of the Royal Statistical Society Series A (Statistics in Society). 174(1). 95–107. 50 indexed citations
3.
Costa‐Font, Joan, et al.. (2009). Re-visiting the Health Care Luxury Good Hypothesis: Aggregation, Precision, and Publication Biases?. RECERCAT (Consorci de Serveis Universitaris de Catalunya). 6 indexed citations
4.
Gemmill, Marin, Sarah Thomson, & Elías Mossialos. (2008). What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. International Journal for Equity in Health. 7(1). 12–12. 93 indexed citations
5.
Gemmill, Marin, Joan Costa‐Font, & Alistair McGuire. (2007). In search of a corrected prescription drug Elasticity estimate: a meta‐regression approach. Health Economics. 16(6). 627–643. 50 indexed citations
6.
Gemmill, Marin, Joan Costa‐Font, & Panos Kanavos. (2006). Insurance Coverage and the Heterogeneity of Health and Drug Spending in the United States. The Geneva Papers on Risk and Insurance Issues and Practice. 31(4). 669–691. 7 indexed citations
7.
Kanavos, Panos & Marin Gemmill. (2005). Pharmaceutical pricing and reimbursement in Europe. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 14 indexed citations
8.
Kanavos, Panos & Marin Gemmill. (2004). Senior Citizens and the Burden of Prescription Drug Outlays. Applied Health Economics and Health Policy. 3(4). 217–227. 3 indexed citations
9.
Kanavos, Panos, Joan Costa‐Font, Sherry Merkur, & Marin Gemmill. (2004). The Economic Impact of Pharmaceutical Parallel Trade in European Union Member States: A Stakeholder Analysis. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026